Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrishan S Samuel

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Endocrinology|October 27, 2011
Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ sizeTim D Hewitson, Chongxin Zhao, Belinda Wigg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2026
Corrigendum to "Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice," [Biomed. Pharmacother. 158 (2023) 114069]Yifang Li, Gang Zheng, Ekaterina Salimova, et al.
Life Sciences|May 23, 2026
Serelaxin has greater anti-fibrotic potential than perindopril but maintains its anti-fibrotic efficacy in the presence of perindopril in normotensive mouse models of heart diseaseZiqiao Wang, Gang She, Chao Wang, et al.
Biochemistry|January 15, 2011
H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptorMohammed Akhter Hossain, Bryna Chow Suet Man, Chongxin Zhao, et al.
Endocrine Connections|February 2, 2019
Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesityAnna C Simcocks, Kayte A Jenkin, Lannie O'Keefe, et al.
Plos One|September 1, 2012
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOSBryna Suet Man Chow, Elaine Guo Yan Chew, Chongxin Zhao, et al.
Pharmacology & Therapeutics|February 26, 2020
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosisAnita A Pinar, Tara E Scott, Brooke M Huuskes, et al.
Journal of Cardiovascular Pharmacology|September 28, 2002
Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen contentXiao-Ming Gao, Rodney J Dilley, Chrishan S Samuel, et al.
International Journal of Molecular Sciences|April 13, 2023
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering ActivityPraveen Praveen, Chao Wang, Thomas N G Handley, et al.
Endocrinology|November 1, 2008
Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways diseaseChrishan S Samuel, Simon G Royce, Bin Chen, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Endocrinology|October 27, 2011
Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ sizeTim D Hewitson, Chongxin Zhao, Belinda Wigg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2026
Corrigendum to "Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice," [Biomed. Pharmacother. 158 (2023) 114069]Yifang Li, Gang Zheng, Ekaterina Salimova, et al.
Life Sciences|May 23, 2026
Serelaxin has greater anti-fibrotic potential than perindopril but maintains its anti-fibrotic efficacy in the presence of perindopril in normotensive mouse models of heart diseaseZiqiao Wang, Gang She, Chao Wang, et al.
Biochemistry|January 15, 2011
H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptorMohammed Akhter Hossain, Bryna Chow Suet Man, Chongxin Zhao, et al.
Endocrine Connections|February 2, 2019
Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesityAnna C Simcocks, Kayte A Jenkin, Lannie O'Keefe, et al.
Plos One|September 1, 2012
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOSBryna Suet Man Chow, Elaine Guo Yan Chew, Chongxin Zhao, et al.
Pharmacology & Therapeutics|February 26, 2020
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosisAnita A Pinar, Tara E Scott, Brooke M Huuskes, et al.
Journal of Cardiovascular Pharmacology|September 28, 2002
Lower risk of postinfarct rupture in mouse heart overexpressing beta 2-adrenergic receptors: importance of collagen contentXiao-Ming Gao, Rodney J Dilley, Chrishan S Samuel, et al.
International Journal of Molecular Sciences|April 13, 2023
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering ActivityPraveen Praveen, Chao Wang, Thomas N G Handley, et al.
Endocrinology|November 1, 2008
Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways diseaseChrishan S Samuel, Simon G Royce, Bin Chen, et al.
Pageof 18